|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 53.35 USD | -5.31% |
|
52.50 | -1.59% |
| 30/06 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 84.7 | +50.34% | 20 | |||||||
| 669.22 | +14.87% | 23 | |||||||
| 200.27 | +4.78% | 22 | |||||||
| 229.63 | +9.89% | 19 | |||||||
| 413.05 | +36.4% | 27 | |||||||
| 2,56,664.68 | +48.28% | 24 | |||||||
| 259.99 | +7.9% | 18 | |||||||
| 451.42 | -15.7% | 12 | |||||||
| 71.03 | +3.24% | 14 | |||||||
| 180.81 | +7.14% | 16 | |||||||
| 138.56 | +13.02% | 6 | |||||||
| 220.67 | -5.54% | 15 | |||||||
| 70 | -1.62% | 12 | |||||||
| 66.06 | +7.42% | 16 | |||||||
| 98.27 | +52.91% | 22 | |||||||
| 130.53 | -2.28% | 12 | |||||||
| 123.76 | +4% | 21 | |||||||
| 619.11 | +85.85% | 18 | |||||||
| 50.56 | -5.98% | 16 | |||||||
| 120.54 | -12.42% | 13 | |||||||
| Average | 13,043.14 | +15.12% | 17 | ||||||
| Weighted average by Cap. | 19,365.61 | +15.45% | 19 |
- Stock Market
- Stocks
- CRSP Stock
- Sector CRISPR Therapeutics AG
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















